MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹78 Cr | ₹85 Cr | ₹83 Cr | ₹73 Cr | ₹53 Cr |
What is the latest Total Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹78 Cr |
| Mar2024 | ₹85 Cr |
| Mar2023 | ₹83 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹53 Cr |
How is Total Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹78 Cr | -7.56 | |
| Mar2024 | ₹85 Cr | 2.40 | |
| Mar2023 | ₹83 Cr | 13.60 | |
| Mar2022 | ₹73 Cr | 36.45 | |
| Mar2021 | ₹53 Cr | - | |
Compare Total Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹523.1 Cr | 9.3% | 24.6% | -31% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | 9.3% |
24.6% |
-31% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses